【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market overview
03.2 Product offerings
04.Product Profiles
04.1.1 Celexa
04.1.2 Fetzima
04.1.3 Lexapro
04.1.4 Viibryd
04.1.5 Cymbalta
04.1.6 Prozac
04.1.7 Symbyax
04.1.8 Paxil
04.1.9 Wellbutrin
04.1.10 Abilify
04.1.11 Effexor
04.1.12 Pristiq
04.1.13 Zoloft
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disorder Overview
07.1 Types of depression
07.1.1 Major depressive disorder
07.1.2 Persistent depressive disorder
07.1.3 Psychotic depression
07.1.4 Postpartum depression
07.1.5 Seasonal affective disorder
07.1.6 Bipolar disorder
07.2 Etiology
07.3 Epidemiology
07.3.1 Bipolar disorder among adults
07.3.2 Dysthymic disorder among adults
07.3.3 Major depression among adults
07.3.4 Major depression among adolescents
07.4 Treatment and management
07.5 Economic burden
08.Market Landscape
08.1 Market overview
08.2 Market size and forecast
08.3 Depression drugs market in US 2014-2019
08.3.1 Market size and forecast
08.4 Five forces analysis
09.Market Segmentation by Mechanism of Action
10.Geographical Segmentation
10.1 Segmentation of global depression drugs market by geography 2014
11.Pipeline Portfolio
11.1 Key information on late-stage pipeline molecules
11.1.1 Brexpiprazole
11.1.2 ALKS 5461
11.1.3 Cariprazine
11.1.4 TGFK07AD
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Vendor Landscape
19.1 Competitive scenario
19.1.1 Key news
19.1.2 Mergers and acquisitions
19.2 Market share analysis 2014
19.2.1 Competitive assessment of top drugs used for treating depression
19.2.2 Bristol-Myers Squibb
19.2.3 Eli Lilly
19.2.4 Pfizer
19.2.5 GlaxoSmithKline
19.2.6 Actavis
19.3 Other and future prominent vendors
20.Key Vendor Analysis
20.1 Actavis
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation
20.1.4 Business Segmentation by Revenue 2012 and 2013
20.1.5 Geographical segmentation by Sales 2013
20.1.6 Business Strategy
20.1.7 Recent Developments
20.1.8 SWOT Analysis
20.2 Bristol-Myers Squibb
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Key Product Offerings
20.2.4 Revenue by Geography
20.2.5 Business Strategy
20.2.6 Key Information
20.2.7 SWOT Analysis
20.3 Eli Lilly
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue
20.3.4 Sales by Geography
20.3.5 Business Strategy
20.3.6 Key Information
20.3.7 SWOT Analysis
20.4 GlaxoSmithKline
20.4.1 Key facts
20.4.2 Business overview
20.4.3 Business segmentation by revenue 2014
20.4.4 Business segmentation by revenue 2013 and 2014
20.4.5 Geographical segmentation by revenue 2014
20.4.6 Business strategy
20.4.7 Recent developments
20.4.8 SWOT analysis
20.5 Pfizer
20.5.1 Key facts
20.5.2 Business overview
20.5.3 Business segmentation by revenue 2014
20.5.4 Business segmentation by revenue 2013 and 2014
20.5.5 Geographical segmentation by revenue 2014
20.5.6 Business strategy
20.5.7 Key developments
20.5.8 SWOT analysis
21.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: NIMH classification of depression
Exhibit 3: Prevalence data for major depressive disorder among adults in US (2012)
Exhibit 4: Prevalence data for dysthymic disorder among adults in US (2012)
Exhibit 5: 12-month prevalence data for major depressive disorder with severe impairment among adults in US (2012)
Exhibit 6: Prevalence data for major depressive disorder among adults in US (2012)
Exhibit 7: Prevalence data for major depression among adults in US (2012)
Exhibit 8: WHO guidelines for management of depression
Exhibit 9: Economic burden of depression in US
Exhibit 10: Segmentation of costs associated with depression
Exhibit 11: Snapshot of economic burden of depression in US
Exhibit 12: Global depression drugs market 2014-2019 ($ millions)
Exhibit 13: Depression drugs market in US 2014-2019 ($ millions)
Exhibit 14: Segmentation of global depression drugs market by mechanism of action
Exhibit 15: Segmentation of global depression drugs market by mechanism of action 2014
Exhibit 16: Segmentation of global depression drugs market by geography 2014
Exhibit 17: Depression drugs: pipeline portfolio
Exhibit 18: Vendor ranking 2014
Exhibit 19: YoY growth rate of major depression drugs 2010-2014 ($ millions)
Exhibit 20: Revenue comparison of top drugs used for treating depression in 2013 ($ millions)
Exhibit 21: YoY global revenue of Abilify 2010-2014 ($ millions)
Exhibit 22: YoY global revenue of Cymbalta 2010-2014 ($ millions)
Exhibit 23: YoY global revenue of Pristiq 2010-2014 ($ millions)
Exhibit 24: YoY global revenue of Zoloft 2010-2014 ($ millions)
Exhibit 25: YoY global revenue of Effexor 2010-2014 ($ millions)
Exhibit 26: YoY global revenue of Wellbutrin 2010-2013 ($ millions)
Exhibit 27: YoY revenue of Wellbutrin in US 2010-2013 ($ millions)
Exhibit 28: YoY global revenue of Paxil 2010-2014 ($ millions)
Exhibit 29: Actavis: Business Segmentation
Exhibit 30: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 31: Actavis: Geographical segmentation by Sales 2013
Exhibit 32: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 33: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 34: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 35: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 36: Eli Lilly: Sales by Geography 2013
Exhibit 37: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 38: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 39: GlaxoSmithKline: Geographical segmentation by revenue 2014
Exhibit 40: Pfizer: Business segmentation by revenue 2014
Exhibit 41: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 42: Pfizer: Geographical segmentation by revenue 2014
【レポート販売概要】
■ タイトル：うつ病治療薬の世界市場2015-2019■ 英文：Global Depression Drugs Market 2015-2019
■ 発行日：2015年6月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR6053
■ 調査対象地域：グローバル
- 3Dセンサの世界市場：イメージセンサ、ポジションセンサ、加速度計、音響センサThe 3D sensors market is expected to reach USD 5.46 Billion by 2022, at a CAGR of 26.5% between 2016 & 2022. The growth of the market is driven by factors such as the rising demand for 3D-enabled devices in consumer electronics, integration of the optical and electronic components, the use of sensing technology in gaming applications, and the growing requirement for security & surveillance systems …
- ソフトウェア定義データセンター（SDDC）の世界市場：ソフトウェア定義ネットワーク（SDN）、ソフトウェア定義ストレージ（SDS）、ソフトウェア定義コンピュート（SDC）、アプリケーションThe Software Defined Data Center (SDDC) market is estimated to grow from USD 25.61 Billion in 2016 to USD 83.21 Billion by 2021, at a high Compound Annual Growth Rate (CAGR) of 26.57% during the forecast period. SDDC solutions are gaining a significant importance among the corporates due to the increasing network traffic and efficient use of data center resources that helps in cutting down the cos …
- ソーシャルメディア、モノのインターネット、ヘルスケアの未来（Social Media, Internet of Things, and the Future of Public Health）Public health is "the science and art of preventing disease, prolonging life and promoting health through the organized efforts and informed choices of society, organizations, public and private, communities and individuals." It is concerned with threats to health based on population health analysis. This definition highlights the role played by members of the community in improving health and in …
- Consolidated Edison Company of New York, Inc.：発電所及びSWOT分析2013Consolidated Edison Company of New York, Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants …
- スマートウィンドウ（Smart Windows)材料市場2014-2021※当レポートはスマートウィンドウの市場機会、ビジネスモデル分析、市場規模予測、主要企業の戦略などをまとめました。 In the past five years or so, smart (i.e. self-dimming) windows have taken off in both residential and commercial building markets. They are also increasingly used in automobiles and trucks. There are several different smart windows technologies, but all of them are materials plays in one way or another. NanoMarkets believes that, as a resul …
- アドバンスドプロセス制御の世界市場：APCソフトウェア、APCサービスAdvanced process control is primarily employed in process industries. Process industries are in continuous pressure to improve the production process without compromising on the quality of the product produced. This has led to the development and implementation of advanced process control systems in process industries. APC represents a set of methods and technologies that are designed to realize a …
- 乾癬市場：日本の治療薬市場Psoriasis - Japan Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and personal angst for p …
- 集光型太陽光発電（CPV）のグローバル市場（2014-2018）About Solar Concentrated Photovoltaics A solar CPV system concentrates sunlight on solar cells with the help of an optical device, increasing the efficiency of photovoltaic cells that convert energy from sunlight directly into electricity. The optics used concentrates the sunlight by a factor of 500 to 1,000 and focuses it on the solar cells, which are reduced to a small fraction of the CPV module …
- ホルモノネチンの世界市場Formononetin (CAS 485-72-3) Market Research Report 2014 presents comprehensive data on formononetin markets globally and regionally (Europe, Asia, North America etc.) The report includes formononetin description, covers its application areas and related patterns. It overviews formononetin market, names formononetin producers and indicates its suppliers. Besides, the report provides formononetin pr …
- 世界のムコン酸市場2015The Global Muconic Acid Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Muconic Acid industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Muconic Acid market analysis is provided for the international markets including development trends, competitive …
- 食品・飲料加工機械のグローバル市場（～2019）The industry report Global Food and Beverage Processing Machine Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for food and beverage processing machines in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource f …
- 再生可能エネルギー政策分析：August 2013Renewable Policy Analysis - August 2013 Summary The “Renewable Policy Analysis” provides in depth study of the major renewable policy developments across the globe. It gives regulatory and other associated updates for the global renewable energy market which can help the individual/company to frame their business strategies while minimizing regulatory risks. For the August 2013 issue, it covers tw …
- 動物用感染症診断の世界市場予測（～2024年）“The global veterinary infectious disease diagnostics market is projected to grow at a CAGR of 8.4% during the forecast period” Veterinary infectious disease diagnostics includes immunodiagnostic, molecular diagnostic, and other veterinary diagnostic technologies. Diagnosis is conducted using kits, reagents, consumables, and analyzers that determine the nature and cause of infectious disease and t …
- 世界の再保険（Reinsurance）市場動向（2014～2018）TechNavio's analysts forecast the Global Reinsurance market to grow at a CAGR of 3.13 percent over the period 2013-2018. One of the key factors contributing to this market growth is the robust growth of the global economy. The Global Reinsurance market has also been witnessing the growth in urbanization across the globe. However, the delayed implementation of Solvency II regulations is delaying gr …
- 世界のB型肝炎ワクチン市場（2014-2018）About Hepatitis B Vaccines Hepatitis B is an inflammatory condition that occurs due to infection by hepatitis B virus. Hepatitis B virus is an enveloped virus that belongs to the family of hepadnavirus. It contains a circular genome with partially double-stranded DNA. The virus interferes with the normal functioning of the liver cells. Following the viral infection, the immune system is activated …
